A. M. Jeffrey
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Chemical Health and Safety top 10%
Papers in
-
- Carcinogens and Genotoxicity Assessment 8
-
- Microbial Natural Products and Biosynthesis 5
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- D. M. JERINARob M. J. LiskampGary M. WilliamsT.R. PatelDavid T. GibsonI B WeinsteinMichael J. IatropoulosJames P. Ferris
- Journals
- Environmental Health Perspectives (4 papers)Experimental and Toxicologic Pathology (2 papers)Journal of the American Chemical Society (1 paper)Food and Chemical Toxicology (1 paper)European Journal of Cancer Prevention (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
A. M. Jeffrey
33 papers receiving 940 citations
Peers
Comparison fields: 5 of 103
- Cancer Research 341
- Chemical Health and Safety 11
- Health, Toxicology and Mutagenesis 203
- Pollution 161
- Pharmacology 101
Countries citing papers authored by A. M. Jeffrey
This map shows the geographic impact of A. M. Jeffrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Jeffrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Jeffrey more than expected).
Fields of papers citing papers by A. M. Jeffrey
This network shows the impact of papers produced by A. M. Jeffrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Jeffrey. The network helps show where A. M. Jeffrey may publish in the future.
Co-authors
The 25 scholars most cited alongside A. M. Jeffrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 3 | |
| 2 | 2012 | 114 | |
| 3 | 2011 | 13 | |
| 4 | 2002 | 14 | |
| 5 | Anticarcinogenicity of monocyclic phenolic compounds. | 2002 | 15 |
| 6 | 2001 | 8 | |
| 7 | 2000 | 42 | |
| 8 | 1998 | 39 | |
| 9 | 1992 | 5 | |
| 10 | 1992 | 23 | |
| 11 | 1991 | 9 | |
| 12 | 1991 | 22 | |
| 13 | 1989 | 11 | |
| 14 | 1989 | 4 | |
| 15 | 1986 | 90 | |
| 16 | 1985 | 11 | |
| 17 | Initial cellular targets and eventual genomic changes in multistage carcinogenesis. | 1984 | 4 |
| 18 | 1983 | 6 | |
| 19 | Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism. | 1983 | 44 |
| 20 | 1975 | 201 |
About A. M. Jeffrey
A. M. Jeffrey is a scholar working on Cancer Research, Pharmacology, Pharmacology, Pharmaceutical Science and Biochemistry, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Microbial Natural Products and Biosynthesis (5 papers), Effects and risks of endocrine disrupting chemicals (2 papers), DNA Repair Mechanisms (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Cancer Research (341 citations), Chemical Health and Safety (11 citations), Health, Toxicology and Mutagenesis (203 citations), Pollution (161 citations) and Pharmacology (101 citations). A. M. Jeffrey has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include D. M. JERINA, Rob M. J. Liskamp, Gary M. Williams, T.R. Patel, David T. Gibson, I B Weinstein, Michael J. Iatropoulos, James P. Ferris, Michael J. Fasco and Regina M. Santella. Their work appears in journals such as Environmental Health Perspectives, Experimental and Toxicologic Pathology, Journal of the American Chemical Society, Food and Chemical Toxicology and European Journal of Cancer Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.